Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $410.66 million. The enterprise value is $458.16 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 14.37 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.37M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 33.46% |
| Owned by Institutions (%) | 23.75% |
| Float | 5.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.95 |
| Forward PS | n/a |
| PB Ratio | 2.00 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.49.
| Current Ratio | 1.09 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.20 |
Financial Efficiency
Return on equity (ROE) is -24.36% and return on invested capital (ROIC) is -5.52%.
| Return on Equity (ROE) | -24.36% |
| Return on Assets (ROA) | -3.65% |
| Return on Invested Capital (ROIC) | -5.52% |
| Return on Capital Employed (ROCE) | -11.41% |
| Revenue Per Employee | $304,933 |
| Profits Per Employee | -$86,239 |
| Employee Count | 765 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.78 |
Taxes
In the past 12 months, Zepp Health has paid $14.04 million in taxes.
| Income Tax | 14.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +888.93% in the last 52 weeks. The beta is 1.42, so Zepp Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | +888.93% |
| 50-Day Moving Average | 38.83 |
| 200-Day Moving Average | 19.91 |
| Relative Strength Index (RSI) | 44.26 |
| Average Volume (20 Days) | 245,010 |
Short Selling Information
| Short Interest | 396,343 |
| Short Previous Month | 749,598 |
| Short % of Shares Out | 6.57% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.64 |
Income Statement
In the last 12 months, Zepp Health had revenue of $233.27 million and -$65.97 million in losses. Loss per share was -$4.14.
| Revenue | 233.27M |
| Gross Profit | 86.70M |
| Operating Income | -34.30M |
| Pretax Income | -51.96M |
| Net Income | -65.97M |
| EBITDA | -31.28M |
| EBIT | -34.30M |
| Loss Per Share | -$4.14 |
Full Income StatementBalance Sheet
The company has $62.74 million in cash and $110.25 million in debt, giving a net cash position of -$47.51 million or -$3.31 per share.
| Cash & Cash Equivalents | 62.74M |
| Total Debt | 110.25M |
| Net Cash | -47.51M |
| Net Cash Per Share | -$3.31 |
| Equity (Book Value) | 226.34M |
| Book Value Per Share | 14.31 |
| Working Capital | 25.84M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 37.17%, with operating and profit margins of -14.70% and -28.28%.
| Gross Margin | 37.17% |
| Operating Margin | -14.70% |
| Pretax Margin | -22.27% |
| Profit Margin | -28.28% |
| EBITDA Margin | -13.41% |
| EBIT Margin | -14.70% |
| FCF Margin | n/a |
Dividends & Yields
Zepp Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | -16.07% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 16, 2024. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
Zepp Health has an Altman Z-Score of 0.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.5 |
| Piotroski F-Score | 1 |